Echinacea, Elderberry, Pelargonium: Which Herbal Cold Remedies Hold Up in Studies
Echinacea, elderberry and South African geranium are among the most popular herbal remedies for colds. The studies tend to show small effects on duration and symptoms, partly contradictory results and big differences between products. Here I place all three side by side, with their limits and a clear line where real flu begins.
A cold is a nuisance, but usually harmless. That is exactly why it attracts big promises. I want you to know what a remedy can do before you give it your hope.
It is November. It has been drizzling for days, and half the office is sniffling. Then one evening your throat starts to scratch.
A shelf full of immune defences
The next morning you are standing in the pharmacy. In front of you, a shelf full of syrups, drops, lozenges and teas. Echinacea, elderberry, pelargonium, zinc.
Almost every pack claims to strengthen your defences. You reach for one, because you need to function tomorrow. Three days later you feel better, and the little bottle gets the applause.
A cold usually settles by itself, with or without the bottle. That is exactly why you need studies with a comparison group if you want to know what a remedy itself contributes.
Herbal cold remedies are popular, and I understand why. They feel gentle, familiar and a little like taking matters into your own hands. The only question is: which of them stand up to an honest test?
The starting point is sobering. A 2024 Cochrane review states that there is so far no established measure that prevents colds or shortens their duration. So every remedy starts from zero and has to prove itself.
What to expect here
- What happens in your body during a cold
- Cold or flu: where the line runs
- Echinacea: a family name, not an active ingredient
- Elder: flower and berry are two remedies
- South African geranium: studies and the liver warning
- All three in direct comparison
- Sleep, stress, vitamin D and zinc
- Three levers for your next infection
What happens in your body during a cold?
Your nose is running, your head feels heavy, and all you want is to crawl under the covers. It feels as if a virus has taken over. May I offer you a different view?
Colds are triggered by many different viruses. According to a 2003 review from Turku in Finland, rhinoviruses play the biggest role. In about a quarter of all colds, the pathogen remained unknown at the time.
This matters for everything that follows. A cold remedy would have to work against many different pathogens, not against a single one.
On top of that, a large part of your symptoms does not come directly from the virus, but from your own defences. A team at the University of British Columbia in Vancouver showed this in the laboratory using human bronchial cells. Cold viruses caused the cells to release messenger substances such as interleukin-6 and interleukin-8.
Imagine these messengers as smoke alarms. They call in immune cells, make the mucous membranes swell and get the mucus flowing. Loud, unpleasant, but part of the defence.
Immune system
Infected mucosal cells send out alarm signals. Immune cells flood in, and your nose swells and runs. Annoying, but a sign that your defences are at work.
Nervous system
Inflammatory messengers also reach the brain. Tiredness, withdrawal and a poor appetite are part of a sickness behaviour that might keep energy free for your defences.
Hormonal system
Chronic stress can weaken your defences. In a classic study, the rate of colds rose with the stress level. Stress hormones such as cortisol are considered one possible pathway, but this has not been conclusively settled.
Metabolism
Immune cells need energy and building blocks such as zinc. Lack of sleep and nutrient deficiencies might shrink the reserves your defences draw on.
From the perspective of clinical psychoneuroimmunology, KPNI for short, a cold is therefore a whole-body event. Nervous system, hormones, metabolism and immune system negotiate with each other about how much strength flows into your defences.
Anthroposophic medicine also describes an infection as a process the organism goes through, not just as a disturbance. That is a view from tradition, not a study result. I still find it valuable, because it shifts the focus from the symptom to the whole person.
A runny nose, a sore throat and tiredness are more the alarm system than the burglar. If you only turn the alarm down, you have not yet chased the burglar away.
A good cold remedy would therefore have to measurably shorten or soften the course of the illness. That is exactly the standard I hold the three plants to.
And now you know why I ask the same question about every cold remedy: does it change the course of the illness, or does it just feel like doing something?
Cold or flu: where is the line?
Sometimes it is not a scratch, but a blow. At lunchtime you were still fine, by evening you have a high fever and every muscle aches. That feels different from a sniffle. Usually, it is.
Short answer: a cold usually starts gradually, with a scratchy throat and a runny nose. Flu often starts suddenly, with high fever, aching limbs and feeling very ill. Flu is a separate illness, and in risk groups it belongs in medical hands early.
Cold
- Starts gradually, over one or two days
- Runny nose, sneezing and a scratchy throat dominate
- No fever, or usually only a moderate one
- You feel run down, but can often still get things done
Flu (influenza)
- Often starts suddenly, within hours
- High fever, chills, muscle aches and aching limbs
- Dry cough and feeling markedly unwell
- Complications such as pneumonia are possible
Only a test can reliably tell the two apart. The difference still matters, because there are antiviral medicines against flu. The guideline of the Infectious Diseases Society of America, IDSA, recommends starting them as early as possible in people at increased risk.
According to the guideline, these risk groups include people aged 65 and over, children under two and pregnant women, among others. Added to these are people with chronic diseases of the heart, lungs, kidneys, liver or metabolism, and people with a weakened immune system. In otherwise healthy adults, treatment can be considered if symptoms have lasted no more than two days.
This is exactly where this article draws its line. The plants we are about to look at are not an alternative in real flu. A careful study of elderberry extract in confirmed flu found no benefit. More on that shortly.
- Sudden onset with high fever and feeling very ill, especially during flu season
- Shortness of breath, chest pain or pus-like phlegm
- Fever that lasts several days, or getting worse again after initial improvement
- Symptoms that last longer than ten days
- You are 65 or older, pregnant, chronically ill or immunocompromised
- Babies and toddlers with fever, poor feeding or unusual breathing
- If you are severely short of breath: call the emergency number 112 immediately
Whether an annual flu vaccination makes sense for you is something you can discuss with your GP in the autumn. That is the subject of a separate conversation, not of this article.
Flu is not a bad cold. It is a separate illness with its own risks.
If you treat it like a sniffle, you may waste the window of time in which antiviral medicines could do the most.
And now you know why the first question in November is not which syrup, but which infection.
What can echinacea do for a cold?
For many people, echinacea is the ultimate cold remedy. Maybe the drops already stood in your parents' bathroom cabinet. But if you read the studies, you quickly become unsure. Some are enthusiastic, others wave it away. How can that be?
Short answer: for prevention, studies point to a small effect, while for treating a cold that has already started, a benefit is barely established. What a product can contribute depends heavily on species, plant part and preparation.
A family name, not an active ingredient
Three species go by the name echinacea: purple coneflower, narrow-leaved coneflower and pale purple coneflower. The herb, the root or both are used. Sometimes freshly pressed, sometimes as an alcoholic extract, sometimes dried in tablets.
A juice pressed from the fresh herb and a tablet made from dried root are as different as apple juice and ground apple seeds. Both carry the same name. In your body, they can behave entirely differently.
In August 2000, a team at the University of Colorado in Denver bought one of each single-ingredient echinacea product available in several shops in the Denver area. In 6 of 59 products, or 10 percent, no echinacea at all could be measured. Only in 31 products, 52 percent, did the species contained match the label.
Of 21 products labelled as standardised, only 9 met the stated standard. The analysis comes from the USA and is more than 20 years old. But it shows how little a name reveals about the contents.
Gilroy CM, Steiner JF, Byers T, Shapiro H, Georgian W. Arch Intern Med. 2003;163(6):699-704. DOI: 10.1001/archinte.163.6.699What the large analyses show
A team led by Karsch-Völk at the Institute of General Practice at the Technical University of Munich summarised 24 double-blind studies with 4,631 participants. Because the preparations differed so much, the team deliberately refrained from calculating an overall figure in the main analysis. None of the twelve prevention comparisons was statistically significant on its own, but a post hoc pooling points to a relative risk reduction of 10 to 20 percent.
For treatment, only one of seven studies showed a significantly shorter duration of colds. The authors consider a weak benefit of individual products possible, but its clinical relevance questionable. For you, this means: if at all, then rather for prevention and on a small scale.
Karsch-Völk M, Barrett B, Kiefer D, Bauer R, Ardjomand-Woelkart K, Linde K. Cochrane Database Syst Rev. 2014;(2):CD000530. DOI: 10.1002/14651858.CD000530.pub3Other analyses sound friendlier. A 2007 meta-analysis from the University of Connecticut calculated from 14 studies 58 percent lower odds of catching a cold and a duration shortened by 1.4 days. The Cochrane authors later explicitly refrained from such an overall calculation across very different preparations.
A team led by Schapowal from Landquart in Switzerland selected six methodologically high-quality studies with 2,458 participants. With echinacea, recurrent respiratory infections occurred less often, with a relative risk of 0.649. In people with increased susceptibility or under stress, the risk roughly halved, and complications such as pneumonia or middle ear infection were less frequent.
Alcoholic extracts performed better than pressed juices. However, the selection was narrow, and the statistical model assumes that all studies measure the same effect. For you, this means: an interesting signal for people with frequent infections, but not a confirmed finding.
Schapowal A, Klein P, Johnston SL. Adv Ther. 2015;32(3):187-200. DOI: 10.1007/s12325-015-0194-4A four-month study from the Common Cold Centre at Cardiff University with 755 healthy adults points in the same direction. It tested an alcoholic extract of fresh purple coneflower, mostly herb with a little root. The echinacea group had fewer colds, fewer cold days and fewer episodes in which painkillers were used. Adverse events occurred about as often as with placebo.
A team led by Barrett at the University of Wisconsin in Madison divided 719 people with a starting cold into four groups: no pills, placebo, blinded echinacea and open-label echinacea. With blinded echinacea, the cold lasted 6.34 days on average, with placebo 6.87 days. The difference of just over half a day was not statistically significant.
For comparison: with no pills at all, the cold lasted 7.03 days. The tablets tested were based on dried echinacea root. For you, this means: even in the best case, this was about hours, not days.
Barrett B, Brown R, Rakel D, Mundt M, Bone K, Barlow S, Ewers T. Ann Intern Med. 2010;153(12):769-777. DOI: 10.7326/0003-4819-153-12-201012210-00003A team led by Taylor at the University of Washington in Seattle gave 407 children purple coneflower or placebo at the start of an infection. Across 707 infections, there was no difference in duration or severity, and on average an infection lasted nine days. A rash, on the other hand, occurred more often with echinacea, in 7.1 percent of infections compared with 2.7 percent with placebo.
The EU monograph advises against echinacea in children under twelve because sufficient data are lacking. For parents, this means: in children, reaching for echinacea is the least well-founded choice.
Taylor JA, Weber W, Standish L, Quinn H, Goesling J, McGann M, Calabrese C. JAMA. 2003;290(21):2824-2830. DOI: 10.1001/jama.290.21.2824And in the laboratory? The Vancouver team showed that an alcoholic extract of herb and root dampened the release of alarm signals in bronchial cells for all the viruses tested. It also inactivated enveloped viruses. Rhinoviruses, the most common cold viruses, do not have such an envelope, however.
When you should avoid echinacea
Echinacea belongs to the daisy family, like chamomile, arnica or calendula. If you are allergic to this plant family, the EU monograph lists echinacea as unsuitable. People prone to allergies should seek medical advice beforehand, because severe hypersensitivity reactions are possible.
An analysis from Australia shows how serious this can be. Two Australian doctors evaluated 51 reports to the national adverse drug reactions committee. Of these, 26 were consistent with an immediate allergic reaction, including 4 cases of anaphylaxis and 12 acute asthma attacks. Striking: 20 out of 100 people prone to allergies reacted to echinacea in a skin test, even though they had never taken it.
In autoimmune diseases such as Hashimoto's, multiple sclerosis or rheumatoid arthritis, the EU monograph advises against echinacea. The same applies to immune deficiency, to immunosuppression such as after an organ transplant, to progressive systemic diseases and to diseases of the white blood cells. The concern behind this: a remedy that influences the immune system might give a misdirected immune response an additional push.
This has not been proven. A pharmaceutical team at the University of Graz even considers these restrictions questionable, because some fat-soluble preparations tend to dampen cellular immune responses. The monograph nevertheless remains cautious: a link with autoimmune diseases cannot be ruled out. I stick to the more cautious line. With Hashimoto's or another autoimmune disease, there are levers that raise fewer questions.
On duration: the monograph limits use to a maximum of ten days, for prevention as well as treatment, and advises starting at the first signs. Prevention studies, by contrast, sometimes ran for months, and the Graz team saw no toxicological concerns in long-term studies of up to six months. During pregnancy and breastfeeding, the monograph advises against it, unless on medical advice.
The question is not whether echinacea can do anything. The question is: which echinacea, for whom, when and for how long?
Without these four answers, any experience is hard to interpret, the good ones as well as the bad.
And now you know why two people can have entirely different experiences with “echinacea”.
What can elderberry do for a cold?
There is something homely about elder. The shrub by the garden fence, the white flower clusters in early summer, the black berries in late summer. Many people remember hot elderberry juice from childhood. How much of this does research support?
Short answer: small studies suggest that elderberry extracts might shorten and ease a cold. In confirmed flu, a careful study showed no benefit. In the EU, elderflowers are classified as a traditional remedy for relieving early cold symptoms.
Flower and berry: two remedies on the same shrub
With elder, two quite different plant parts are used. The flowers end up in your cup as tea. The berries as juice, syrup or extract in capsules and lozenges.
For elderflowers, the European Medicines Agency, EMA, maintains a monograph as a traditional herbal medicinal product. According to it, they can be used to relieve early cold symptoms. This classification is based on long-standing use, not on clinical studies.
For the berries, by contrast, the responsible committee did not adopt a monograph after its review. The assessment ended in 2014 with a public statement. Yet most of the studies you find in product descriptions concern precisely extracts from the berries.
A team at Griffith University in Queensland followed 312 economy class passengers on long-haul flights from Australia. They received a standardised elderberry extract or placebo. There were 17 colds in the placebo group and 12 in the elderberry group, a difference that was not statistically significant.
The duration, however, differed clearly: 117 cold days with placebo, 57 with elderberry, and the symptoms were milder too. The authors themselves call for further studies. For you, this means: elderberry might influence the course of a cold more than the risk of catching one.
Tiralongo E, Wee SS, Lea RA. Nutrients. 2016;8(4):182. DOI: 10.3390/nu8040182In 2019, a meta-analysis from the Franklin Institute of Wellness in Tennessee pooled randomised studies on colds and flu with a total of only 180 participants. It reports a marked reduction in respiratory symptoms. With so few people, however, even single studies can shift the overall picture considerably.
In 2021, a team led by Wieland at the Center for Integrative Medicine at the University of Maryland reviewed the evidence and found five randomised studies. Their conclusion: elderberry may not reduce the risk of catching a cold. It might reduce the duration and severity of a cold and the duration of flu, but the evidence for this is uncertain.
The authors found no evidence that elderberry dangerously overstimulates the immune system. This concern had arisen during the COVID-19 pandemic. For you, this means: probably well tolerated, but not reliably effective.
Wieland LS, Piechotta V, Feinberg T, Ludeman E, Hutton B, Kanji S, Seely D, Garritty C. BMC Complement Med Ther. 2021;21(1):112. DOI: 10.1186/s12906-021-03283-5A team at the Cleveland Clinic treated 87 children aged five and over and adults with laboratory-confirmed flu whose symptoms had been present for less than 48 hours. They received elderberry extract or placebo for five days and could additionally choose the antiviral flu drug oseltamivir. It took 4.9 days with placebo and 5.3 days with elderberry until all symptoms were at most mild, with no significant difference.
Earlier small studies had reported an illness duration about four days shorter in flu, and this study explicitly contradicts that. In a post hoc analysis, elderberry without a flu drug even performed two days worse than placebo without a flu drug, although this is only an indication. For you, this means: in real flu, elderberry does not replace medical treatment.
Macknin M, Wolski K, Negrey J, Mace S. J Gen Intern Med. 2020;35(11):3271-3277. DOI: 10.1007/s11606-020-06170-wIn the laboratory, things look friendlier. In cell cultures at Justus Liebig University Giessen, a standardised elderberry extract inhibited the replication of flu viruses and the growth of some respiratory bacteria. So an effect is biologically plausible. The Cleveland study shows how big the step from test tube to human being can be.
Raw, unripe, stalks: where elder gets tricky
Elderberries are not a harmless snack fruit. Unripe berries contain sambunigrin, a substance from which hydrogen cyanide can form. The content drops as the berries ripen, as a team at the University of Innsbruck describes. In an analysis from the University of Ljubljana, leaves and flowers contained more of these substances than the berries.
That is why an old rule applies in the kitchen: only ripe berries, without stalks, and traditionally only cooked, never raw. For elderflower tea, the monograph advises against use in children under twelve and during pregnancy and breastfeeding, because data are lacking. If shortness of breath, fever or pus-like phlegm develop, the infection should be checked by a doctor.
Elder is not one remedy, but two. The flower carries a long tradition, the berry a handful of small studies with contradictory results.
Both can have their place. In real flu, however, that place is not the front row.
And now you know why, with elder, one question comes first: flower or berry?
What does the evidence show for South African geranium?
Many people know South African geranium only as drops at the first sign of a cough. The plant comes from southern Africa, and it is the root that is used. That sounds exotic and thoroughly researched at the same time. Are both true?
Short answer: studies with one particular root extract report faster relief of cold symptoms. The Cochrane authors, however, rate the evidence for colds as very low. There is also an official warning about rare liver damage.
In Germany, an extract from the root is licensed as a medicine for acute bronchitis. At EU level, the EMA lists the root as a traditional herbal medicinal product for relieving cold symptoms. Most of the studies I cite here use the same special extract.
A team led by Timmer at the Leibniz Institute for Prevention Research and Epidemiology in Bremen assessed the studies on acute respiratory infections. For colds, it found only one study: a benefit appeared after ten days but not after five, with very low quality of evidence. In acute bronchitis, there was a benefit for the liquid preparation, but not for tablets.
Side effects were more common with pelargonium, but not serious. The authors also suspect that unfavourable results were published less often. For you, this means: a possible benefit, accompanied by clear doubts.
Timmer A, Günther J, Motschall E, Rücker G, Antes G, Kern WV. Cochrane Database Syst Rev. 2013;(10):CD006323. DOI: 10.1002/14651858.CD006323.pub3A cold study at the National Medical University in Kyiv included 103 adults whose symptoms had been present for 24 to 48 hours. After ten days, 78.8 percent of the pelargonium group were considered clinically recovered, compared with 31.4 percent with placebo. Those treated were unable to work for 6.9 days on average, the placebo group for 8.2 days.
A 2019 meta-analysis pooled five studies with 833 adults, all using the same root extract over ten days. On day five, symptoms were milder with the extract, and more people were entirely free of symptoms, with a relative risk of 2.52. Those treated missed work less often and needed less paracetamol.
According to the publication, two members of the author team work in the manufacturer's clinical research. That is no reason to dismiss the data. But it is a reason to wait for independent confirmation.
Schapowal A, Dobos G, Cramer H, Ong KC, Adler M, Zimmermann A, Brandes-Schramm J, Lehmacher W. Heliyon. 2019;5(11):e02904. DOI: 10.1016/j.heliyon.2019.e02904A virology team at Goethe University Frankfurt tested the root extract in cell cultures against various respiratory viruses. It interfered with the replication of seasonal flu viruses, RS viruses, parainfluenza viruses and a human coronavirus. Of all things, rhinoviruses, the most common cold viruses, remained unaffected.
Laboratory findings cannot be transferred directly to humans. But they show why a blanket “antiviral” falls short.
Michaelis M, Doerr HW, Cinatl J. Phytomedicine. 2011;18(5):384-386. DOI: 10.1016/j.phymed.2010.09.008In a study from the manufacturer's preclinical research, researchers used components of bacterial cell walls to trigger sickness behaviour in mice: withdrawal, lack of drive, poor appetite. The root extract eased these signs. This fits the picture from the first section that symptoms also arise via inflammatory messengers and the brain.
Mice are not humans, and the study comes from the manufacturer itself. As a mechanism this is plausible, but it has not been shown in humans.
Nöldner M, Schötz K. Phytomedicine. 2007;14 Suppl 6:27-31. DOI: 10.1016/j.phymed.2006.11.013The liver warning: what is behind it
Now to the tricky part. In 2011, Germany's Federal Institute for Drugs and Medical Devices, BfArM, opened a formal drug safety procedure on medicines containing pelargonium. According to the German medical journal Deutsches Ärzteblatt, there were 30 suspected cases of liver damage by mid-2012, including one person who needed a liver transplant. In 2014, the authority ordered a warning about possible liver damage in the package leaflets.
The current 2024 EU monograph also states: cases of liver damage and liver inflammation have been reported, and their frequency is unknown. If there are signs of liver damage, the product should be stopped immediately and medical advice sought.
Whether the plant was actually the cause is disputed. A team led by Teschke at Hanau Hospital in Germany examined 15 reported cases using a liver-specific causality assessment method. In none of the cases was causality rated highly probable or probable, and findings to rule out other causes were often missing.
From 2002 to 2011, the Institute of Clinical Pharmacology and Toxicology at Charité recorded cases of liver injury in all 51 Berlin hospitals. Among 198 cases, a herbal cause was classified as possible or probable in ten. One of these involved South African geranium, classified as a possible cause.
The authors themselves stress that possible causality does not yet prove clinical relevance. For you, this means: the risk appears to be rare, but it cannot be ruled out.
Douros A, Bronder E, Andersohn F, Klimpel A, Kreutz R, Garbe E, Bolbrinker J. Int J Mol Sci. 2016;17(1):114. DOI: 10.3390/ijms17010114- Yellowing of the skin or the whites of the eyes
- Dark urine or noticeably pale stools
- Pain in the upper right abdomen
- Unusual nausea, loss of appetite or itching
If you have a known liver disease, drink alcohol regularly or take several medicines that are broken down by the liver, I would only take pelargonium after talking to a doctor. The monograph also lists nosebleeds and bleeding gums as possible side effects. If you take blood thinners, I would therefore discuss it beforehand.
According to the monograph, liquid preparations are intended from the age of three, and use below that age is not recommended. During pregnancy and breastfeeding, it advises against use because data are lacking. If symptoms last longer than a week, the infection should be checked by a doctor.
Why the liver plays a role with many plants is something you can read in my article on milk thistle and the liver.
Plant-based does not mean harmless, and a warning does not mean dangerous for everyone. Holding both thoughts at once is uncomfortable.
But it is exactly the attitude that lets you use plants responsibly.
And now you know why, with pelargonium, I ask about your liver first and only then about your cough.
How do the three plants compare head to head?
You are standing in front of the shelf again. This time with more knowledge, but perhaps also with more questions. Here is everything at a glance.
Echinacea
Coneflower, three species- Plant part
- Herb, root or both, as pressed juice, extract or tablet
- Evidence
- Many studies, inconsistent. Prevention: possible small effect. Treatment: barely established
- EU classification
- Pressed juice from the fresh herb: well-established use for short-term prevention and treatment
- Timing
- From the first signs, a maximum of ten days according to the monograph
- Caution with
- Daisy family allergy, autoimmune disease, immunosuppression, children under twelve, pregnancy
Elder
Sambucus nigra- Plant part
- Flowers as tea, berries as juice or extract
- Evidence
- A few small studies on berry extracts. Shorter colds possible, no benefit in confirmed flu in a randomised study
- EU classification
- Flowers: traditional use for early cold symptoms. Berries: no monograph
- Timing
- Flower tea at the first symptoms. In the flu study, intake began within 48 hours
- Caution with
- Raw or unripe berries, stalks, children under twelve, pregnancy
South African geranium
Pelargonium sidoides- Plant part
- Root, usually one particular special extract
- Evidence
- Several studies, mostly close to the manufacturer. Cochrane: evidence for colds very low
- EU classification
- Traditional use for cold symptoms
- Timing
- Studies started 24 to 48 hours after symptom onset. If there is no improvement after a week, see a doctor
- Caution with
- Liver disease, liver warning signs, blood thinners, children under three, pregnancy
Supported by meta-analyses, with limitations: a possible small preventive effect for echinacea, symptom relief for pelargonium in studies mostly close to the manufacturer.
Contradictory: elderberry extracts for colds and flu.
Mechanistically plausible, thin in humans: antiviral and anti-inflammatory effects from cell cultures and animal experiments.
Clinical tradition without a strong study base: elderflower tea at the start of a cold.
Open: which preparation might make the difference for which person.
What I often see in my practice: many people take three or four products at the same time. Afterwards, nobody knows what helped and what was a side effect. I prefer one deliberately chosen remedy, for a limited time, to a cocktail.
There is no single best cold plant. There is only the right preparation for the right situation.
And sometimes the right choice is none at all: tea, rest and an early finish at work instead.
And now you know why a comparison matters more than a test winner.
What role do sleep, stress, vitamin D and zinc play?
Honestly: how much did you sleep in the week before it caught you? Many colds do not announce themselves in your throat, but in your calendar.
Short answer: in studies, sleep and stress are closely linked to whether contact with a virus turns into a cold. Vitamin D might slightly lower the risk of infection, and zinc might somewhat shorten a cold that has already started.
A team led by Prather at the University of California, San Francisco, and Carnegie Mellon University measured the sleep of 164 healthy adults for one week with a wrist sensor. Afterwards, everyone had cold viruses dripped into their nose and was observed for five days. People who slept under five hours had 4.50 times higher odds of a cold than those sleeping over seven hours. With five to six hours, the odds were 4.24 times higher.
Between six and seven hours, the risk was not significantly increased. For you, this means: in cold and flu season, sleep is not a side issue, it is defence work.
Prather AA, Janicki-Deverts D, Hall MH, Cohen S. Sleep. 2015;38(9):1353-1359. DOI: 10.5665/sleep.4968A team led by Cohen at Carnegie Mellon University recorded the stress levels of 394 healthy people and then dripped cold viruses into their noses. The higher the stress, the more often infection and colds occurred. The cold rate rose from about 27 to 47 percent.
Smoking, alcohol, exercise, diet or sleep quality did not explain this link. The study is more than 30 years old and is considered a classic of psychoneuroimmunology. For you, this means: chronic stress is also an issue for your mucous membranes.
Cohen S, Tyrrell DA, Smith AP. N Engl J Med. 1991;325(9):606-612. DOI: 10.1056/NEJM199108293250903This is where the KPNI lenses meet. Your nervous system evaluates strain, your hormonal system responds with stress hormones, and your immune system gets less room to manoeuvre. Sleep is the time when many of these systems might reorganise themselves.
How morning light might support your sleep rhythm in the dark half of the year is something you can read in Morning light and your internal clock. Gentle herbal companions for the night are covered in Valerian and passionflower.
Vitamin D: a small but measurable contribution
A team at Queen Mary University of London analysed 46 randomised studies with 75,541 participants. With vitamin D, 61.3 percent had at least one acute respiratory infection, with placebo 62.3 percent. The authors themselves call the risk reduction small, and it was clearest with daily dosing at a moderate dose.
An earlier analysis by the same group using individual participant data found the strongest protection with a very low baseline level below 25 nmol/L. Large single doses given at intervals, on the other hand, showed no protection. For you, this means: vitamin D is not a cold remedy, but an adequate level might be a quiet foundation.
Jolliffe DA, Camargo CA, Sluyter JD et al. Lancet Diabetes Endocrinol. 2021;9(5):276-292. DOI: 10.1016/S2213-8587(21)00051-6 · Martineau AR, Jolliffe DA, Hooper RL et al. BMJ. 2017;356:i6583. DOI: 10.1136/bmj.i6583How sun, winter and vitamin D are connected is something you can read in Vitamin D deficiency in winter. How to take it sensibly is explained in Taking vitamin D the right way.
Zinc: more for the course than for prevention
In 2024, a Cochrane team led by Nault at the Maryland University of Integrative Health analysed 34 studies with 8,526 participants. For prevention, zinc may have reduced the risk of a cold little or not at all, with a relative risk of 0.93. As a treatment, colds were on average 2.37 days shorter, although with low certainty of evidence and very heterogeneous studies.
Non-serious side effects were probably more common during treatment. The possible side effects recorded included a bad taste, loss of smell, vomiting, stomach cramps and diarrhoea. For you, this means: zinc might shorten the course somewhat, but it is not a protective shield.
Nault D, Machingo TA, Shipper AG et al. Cochrane Database Syst Rev. 2024;5(5):CD014914. DOI: 10.1002/14651858.CD014914.pub2A meta-analysis from the University of Helsinki found colds that were 33 percent shorter in seven studies with zinc lozenges. For doses above 100 milligrams a day, there was no indication of a greater benefit. Such amounts are intended for the duration of an infection, not as a long-term solution, and if you have existing conditions they should be discussed with your doctor.
No syrup in the world makes up for a week of five-hour nights. The plants stand in the second row at best.
In the front row stand sleep, a tolerable dose of stress and an adequate vitamin D level.
How nature and rest might take the strain off your stress system is something you can read in Forest bathing for stress.
And now you know why, in autumn, I ask about your sleep first and then about your medicine cabinet.
What can you do now, in practical terms?
You do not have to avoid the shelf. But you can look at it with different eyes.
This is not about a little bottle. It is about the freedom to stay calm in November, because you know what your body can do by itself and where a remedy might usefully support it.
Three levers for your next infection
- Tell them apart first, then choose. Sudden high fever, severe aching limbs or shortness of breath point more towards flu or a complication. If you belong to a risk group, contact your doctor's practice early instead of experimenting.
- If you choose a plant, choose deliberately. Pick one remedy instead of four and check the plant part and preparation on the pack. Start at the first signs and limit the duration. No echinacea if you have an autoimmune disease, no pelargonium without medical advice if you have liver disease, and never eat elderberries raw.
- Protect the foundation. During cold and flu season, plan for more than seven hours of sleep and dose your stress consciously. If you are unsure, have your vitamin D level measured in the autumn.
You may know a similar tension between tradition and studies from my article on black seed oil.
If you don't just want to read but want to get started right away: below this article you will find the option to book an appointment.
Frequently asked questions about herbal cold remedies
Which herbal cold remedies are the best studied?
The best studied are echinacea, or coneflower, as well as South African geranium and elder. For echinacea, there is a Cochrane review of 24 studies with 4,631 participants that found a possible small effect for prevention and hardly any differences for treatment. For pelargonium, there are several studies, mostly close to the manufacturer, reporting faster relief, but the Cochrane authors rate the evidence for colds as very low. For elderberries, there are only a few small studies with contradictory results. None of these remedies replaces a medical assessment when warning signs appear.
Can echinacea shorten a cold?
This has not been reliably shown. In the Cochrane review, only one of seven treatment studies showed a significantly shorter duration of colds. In a University of Wisconsin study with 719 people, the cold lasted 6.34 days on average with echinacea and 6.87 days with placebo, a difference that was not significant. For prevention, a post hoc pooling of studies points to a relative risk reduction of 10 to 20 percent. It is important to know that products differ greatly in species, plant part and preparation.
When should I not take echinacea?
According to the EU monograph, if you are allergic to plants of the daisy family such as chamomile, arnica or calendula. It also advises against use in autoimmune diseases, immune deficiency, immunosuppression, progressive systemic diseases and diseases of the white blood cells. In children under twelve, sufficient data are lacking, and during pregnancy and breastfeeding it should only be used on medical advice. If you are prone to allergies, you should talk to a doctor beforehand, because severe hypersensitivity reactions have been described. The monograph also limits use to a maximum of ten days.
What is the difference between elderflowers and elderberries?
They are two different remedies from the same shrub. In the EU, elderflowers are classified as a traditional herbal medicinal product for relieving early cold symptoms, usually taken as tea, based on long-standing use rather than on clinical studies. For elderberries, the responsible EMA committee has not adopted a monograph. Most clinical studies, however, concern extracts from the berries. You should not use raw or unripe berries, stalks or leaves.
Can elderberry shorten real flu?
One careful study speaks against it. In 87 people with laboratory-confirmed flu, it took 5.3 days with elderberry extract and 4.9 days with placebo until symptoms were at most mild, with no significant difference. Earlier small studies had reported shorter courses, and a systematic review calls the evidence uncertain. There are antiviral medicines against flu, which should be started as early as possible, especially in risk groups. Real flu therefore belongs in medical hands.
Why is there a liver warning for pelargonium?
After reports of suspected liver damage, Germany's Federal Institute for Drugs and Medical Devices ordered a corresponding warning in the package leaflets in 2014. The 2024 EU monograph also lists cases of liver damage and liver inflammation whose frequency is unknown. Whether the plant was the cause is disputed: a review of 15 reports found no probable causality, while a Berlin hospital study classified one case as a possible cause. If you notice yellowing of your skin or eyes, dark urine or upper abdominal pain, you should stop taking it immediately and have it checked by a doctor.
How can I tell whether I have flu and not a cold?
A cold usually starts gradually with a scratchy throat, a runny nose and sneezing, and fever is absent or stays moderate. Flu often starts suddenly with high fever, chills, muscle aches and aching limbs, a dry cough and feeling very ill. Only a test can reliably tell the two apart. If you belong to a risk group, for example if you are 65 or older, pregnant or have a chronic illness, contact a doctor early. Antiviral treatment should then start as early as possible.
When should I see a doctor with a cold?
If you have shortness of breath, chest pain, pus-like phlegm, a high or persistent fever, or if you get worse again after initially improving. Symptoms that last longer than ten days should also be checked by a doctor. For babies, toddlers, pregnant women, older people and people with chronic illness, the threshold is lower. If you are severely short of breath, the emergency number 112 is the right number to call.
Can I take several herbal cold remedies at the same time?
I would rather advise against it. Each remedy brings its own possible side effects, such as allergic reactions with echinacea or rare liver damage with pelargonium, and combinations have barely been studied. If you take several products at the same time, neither a benefit nor a side effect can be attributed afterwards. One deliberately chosen remedy, for a limited time, makes more sense. If you take long-term medication, the choice belongs in a conversation with your doctor or pharmacist.
Are herbal cold remedies suitable for children, pregnant women and breastfeeding mothers?
Only to a limited extent. The EU monographs advise against echinacea and elderflowers in children under twelve, and against liquid pelargonium preparations in children under three. In a study with 407 children, echinacea showed no benefit, and rashes occurred more often. During pregnancy and breastfeeding, the monographs advise against use because data are lacking, in the case of echinacea unless on medical advice. The rule here: talk to a doctor first, then reach for the bottle.
What can zinc and vitamin D do for a cold?
Zinc might somewhat shorten a cold that has already started, by 2.37 days on average in a Cochrane review, although with low certainty of evidence. For prevention, zinc may have lowered the risk little or not at all, and mild side effects were probably more common during treatment. In an analysis of 46 studies, vitamin D slightly lowered the risk of acute respiratory infections. Protection was clearest with daily dosing and, in an earlier analysis, with a very low baseline level. Neither replaces sleep or a medical assessment.
How important is sleep for your defences against colds?
Very important, if you follow the studies. In a study of 164 adults who had cold viruses dripped into their noses, people with less than five hours of sleep had 4.50 times higher odds of a cold than people with more than seven hours. With five to six hours, the odds were 4.24 times higher. Sleep was measured objectively with a wrist sensor. In a classic study, chronic stress was also linked to more frequent colds.
Read on in the ViveCura guide
These articles connect directly to this topic.
Medicinal plants
Phytotherapy with evidence and limits
You are hereAdaptogens explained
What the term promises and what it does not
Medicinal plants and the gut
How herbs might influence the microbiome
Black seed oil
Tradition and studies, fact-checked
Milk thistle and the liver
Detox myth or genuine protection?
Ashwagandha side effects
Why plant-based does not mean harmless
Valerian and passionflower
Herbal companions for sleep
Vitamin D deficiency in winter
Sun, stores and immune defence
Taking vitamin D the right way
With magnesium and K2 in view
Cold exposure and the immune system
What measured cold stimuli might do
Forest bathing for stress
How nature might ease the stress system
Morning light and your internal clock
Sleep rhythm in the dark half of the year
Sources
- Nault D, Machingo TA, Shipper AG, Antiporta DA, Hamel C, Nourouzpour S, Konstantinidis M, Phillips E, Lipski EA, Wieland LS. Zinc for prevention and treatment of the common cold. Cochrane Database Syst Rev. 2024;5(5):CD014914. DOI: 10.1002/14651858.CD014914.pub2 [Systematic review, Cochrane, 34 studies, n=8,526]
- Heikkinen T, Järvinen A. The common cold. Lancet. 2003;361(9351):51-59. DOI: 10.1016/S0140-6736(03)12162-9 [Review]
- Sharma M, Anderson SA, Schoop R, Hudson JB. Induction of multiple pro-inflammatory cytokines by respiratory viruses and reversal by standardized Echinacea, a potent antiviral herbal extract. Antiviral Res. 2009;83(2):165-170. DOI: 10.1016/j.antiviral.2009.04.009 [In vitro, human bronchial cells]
- Cohen S, Tyrrell DA, Smith AP. Psychological stress and susceptibility to the common cold. N Engl J Med. 1991;325(9):606-612. DOI: 10.1056/NEJM199108293250903 [Cohort, prospective, controlled virus exposure, n=394]
- Uyeki TM, Bernstein HH, Bradley JS et al. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenza. Clin Infect Dis. 2019;68(6):e1-e47. DOI: 10.1093/cid/ciy866 [Consensus guideline, IDSA guideline]
- Gilroy CM, Steiner JF, Byers T, Shapiro H, Georgian W. Echinacea and truth in labeling. Arch Intern Med. 2003;163(6):699-704. DOI: 10.1001/archinte.163.6.699 [In vitro, laboratory analysis of 59 commercial products]
- Karsch-Völk M, Barrett B, Kiefer D, Bauer R, Ardjomand-Woelkart K, Linde K. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev. 2014;(2):CD000530. DOI: 10.1002/14651858.CD000530.pub3 [Systematic review, Cochrane, 24 RCTs, n=4,631]
- Shah SA, Sander S, White CM, Rinaldi M, Coleman CI. Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis. Lancet Infect Dis. 2007;7(7):473-480. DOI: 10.1016/S1473-3099(07)70160-3 [Meta-analysis, 14 studies]
- Schapowal A, Klein P, Johnston SL. Echinacea reduces the risk of recurrent respiratory tract infections and complications: a meta-analysis of randomized controlled trials. Adv Ther. 2015;32(3):187-200. DOI: 10.1007/s12325-015-0194-4 [Meta-analysis, 6 RCTs, n=2,458]
- Jawad M, Schoop R, Suter A, Klein P, Eccles R. Safety and efficacy profile of Echinacea purpurea to prevent common cold episodes: a randomized, double-blind, placebo-controlled trial. Evid Based Complement Alternat Med. 2012;2012:841315. DOI: 10.1155/2012/841315 [RCT, n=755]
- Barrett B, Brown R, Rakel D, Mundt M, Bone K, Barlow S, Ewers T. Echinacea for treating the common cold: a randomized trial. Ann Intern Med. 2010;153(12):769-777. DOI: 10.7326/0003-4819-153-12-201012210-00003 [RCT, n=719]
- Taylor JA, Weber W, Standish L, Quinn H, Goesling J, McGann M, Calabrese C. Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial. JAMA. 2003;290(21):2824-2830. DOI: 10.1001/jama.290.21.2824 [RCT, n=407 children]
- Mullins RJ, Heddle R. Adverse reactions associated with echinacea: the Australian experience. Ann Allergy Asthma Immunol. 2002;88(1):42-51. DOI: 10.1016/S1081-1206(10)63591-0 [Case, case series and analysis of 51 reports]
- Ardjomand-Woelkart K, Bauer R. Review and assessment of medicinal safety data of orally used Echinacea preparations. Planta Med. 2016;82(1-2):17-31. DOI: 10.1055/s-0035-1558096 [Review, safety data]
- European Medicines Agency, Committee on Herbal Medicinal Products. European Union herbal monograph on Echinacea purpurea (L.) Moench, herba recens. EMA/HMPC/48704/2014 Corr. Adopted 24 November 2014, corrected version 2015. Monograph (PDF) [Regulatory document]
- European Medicines Agency, Committee on Herbal Medicinal Products. European Union herbal monograph on Sambucus nigra L., flos. EMA/HMPC/611512/2016. Adopted 27 March 2018. Monograph (PDF) [Regulatory document]
- European Medicines Agency. Sambuci fructus: herbal medicinal product. Assessment concluded without an EU monograph, public statement published 29 April 2014. EMA page [Regulatory document]
- Tiralongo E, Wee SS, Lea RA. Elderberry supplementation reduces cold duration and symptoms in air-travellers: a randomized, double-blind placebo-controlled clinical trial. Nutrients. 2016;8(4):182. DOI: 10.3390/nu8040182 [RCT, n=312]
- Hawkins J, Baker C, Cherry L, Dunne E. Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: a meta-analysis of randomized, controlled clinical trials. Complement Ther Med. 2019;42:361-365. DOI: 10.1016/j.ctim.2018.12.004 [Meta-analysis, n=180]
- Wieland LS, Piechotta V, Feinberg T, Ludeman E, Hutton B, Kanji S, Seely D, Garritty C. Elderberry for prevention and treatment of viral respiratory illnesses: a systematic review. BMC Complement Med Ther. 2021;21(1):112. DOI: 10.1186/s12906-021-03283-5 [Systematic review, 5 RCTs]
- Macknin M, Wolski K, Negrey J, Mace S. Elderberry extract outpatient influenza treatment for emergency room patients ages 5 and above: a randomized, double-blind, placebo-controlled trial. J Gen Intern Med. 2020;35(11):3271-3277. DOI: 10.1007/s11606-020-06170-w [RCT, n=87]
- Krawitz C, Mraheil MA, Stein M, Imirzalioglu C, Domann E, Pleschka S, Hain T. Inhibitory activity of a standardized elderberry liquid extract against clinically-relevant human respiratory bacterial pathogens and influenza A and B viruses. BMC Complement Altern Med. 2011;11:16. DOI: 10.1186/1472-6882-11-16 [In vitro, cell culture and bacterial culture]
- Stuppner S, Mayr S, Beganovic A, Beć K, Grabska J, Aufschnaiter U, Groeneveld M, Rainer M, Jakschitz T, Bonn GK, Huck CW. Near-infrared spectroscopy as a rapid screening method for the determination of total anthocyanin content in Sambucus fructus. Sensors (Basel). 2020;20(17):4983. DOI: 10.3390/s20174983 [In vitro, analytical method for elderberries]
- Senica M, Stampar F, Veberic R, Mikulic-Petkovsek M. The higher the better? Differences in phenolics and cyanogenic glycosides in Sambucus nigra leaves, flowers and berries from different altitudes. J Sci Food Agric. 2017;97(8):2623-2632. DOI: 10.1002/jsfa.8085 [In vitro, plant analysis]
- Michaelis M, Doerr HW, Cinatl J. Investigation of the influence of EPs 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses. Phytomedicine. 2011;18(5):384-386. DOI: 10.1016/j.phymed.2010.09.008 [In vitro, cell culture]
- Timmer A, Günther J, Motschall E, Rücker G, Antes G, Kern WV. Pelargonium sidoides extract for treating acute respiratory tract infections. Cochrane Database Syst Rev. 2013;(10):CD006323. DOI: 10.1002/14651858.CD006323.pub3 [Systematic review, Cochrane, 8 studies analysed]
- Lizogub VG, Riley DS, Heger M. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial. Explore (NY). 2007;3(6):573-584. DOI: 10.1016/j.explore.2007.09.004 [RCT, n=103]
- Schapowal A, Dobos G, Cramer H, Ong KC, Adler M, Zimmermann A, Brandes-Schramm J, Lehmacher W. Treatment of signs and symptoms of the common cold using EPs 7630: results of a meta-analysis. Heliyon. 2019;5(11):e02904. DOI: 10.1016/j.heliyon.2019.e02904 [Meta-analysis, 5 RCTs, n=833]
- Nöldner M, Schötz K. Inhibition of lipopolysaccharid-induced sickness behavior by a dry extract from the roots of Pelargonium sidoides (EPs 7630) in mice. Phytomedicine. 2007;14 Suppl 6:27-31. DOI: 10.1016/j.phymed.2006.11.013 [In vivo, mouse]
- European Medicines Agency, Committee on Herbal Medicinal Products. European Union herbal monograph on Pelargonium sidoides DC; Pelargonium reniforme Curt., radix. Final, Revision 2. EMA/HMPC/648100/2022. Adopted 29 May 2024. Monograph (PDF) [Regulatory document]
- Deutsches Ärzteblatt. Pelargoniumhaltige Arzneimittel: BfArM sieht Risiko von Leberschädigungen. News report of 31 March 2014. Article [Medical press, in German, report on the BfArM procedure]
- Teschke R, Frenzel C, Schulze J, Eickhoff A. Spontaneous reports of primarily suspected herbal hepatotoxicity by Pelargonium sidoides: was causality adequately ascertained? Regul Toxicol Pharmacol. 2012;63(1):1-9. DOI: 10.1016/j.yrtph.2012.02.009 [Case, causality assessment of 15 suspected cases]
- Douros A, Bronder E, Andersohn F, Klimpel A, Kreutz R, Garbe E, Bolbrinker J. Herb-induced liver injury in the Berlin Case-Control Surveillance Study. Int J Mol Sci. 2016;17(1):114. DOI: 10.3390/ijms17010114 [Real-world, case-control surveillance in 51 Berlin hospitals, 198 cases]
- Prather AA, Janicki-Deverts D, Hall MH, Cohen S. Behaviorally assessed sleep and susceptibility to the common cold. Sleep. 2015;38(9):1353-1359. DOI: 10.5665/sleep.4968 [Cohort, prospective, controlled virus exposure, n=164]
- Jolliffe DA, Camargo CA, Sluyter JD et al. Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials. Lancet Diabetes Endocrinol. 2021;9(5):276-292. DOI: 10.1016/S2213-8587(21)00051-6 [Meta-analysis, 46 RCTs, n=75,541]
- Martineau AR, Jolliffe DA, Hooper RL et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583. DOI: 10.1136/bmj.i6583 [Meta-analysis, 25 RCTs, n=11,321]
- Hemilä H. Zinc lozenges and the common cold: a meta-analysis comparing zinc acetate and zinc gluconate, and the role of zinc dosage. JRSM Open. 2017;8(5):2054270417694291. DOI: 10.1177/2054270417694291 [Meta-analysis, 7 RCTs, n=575]